These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19887829)

  • 1. Outcomes in CKD: what we know and what we need to know.
    Clark LE; Khan I
    Nephron Clin Pract; 2010; 114(2):c95-102. PubMed ID: 19887829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease.
    Peralta CA; Shlipak MG; Fan D; Ordoñez J; Lash JP; Chertow GM; Go AS
    J Am Soc Nephrol; 2006 Oct; 17(10):2892-9. PubMed ID: 16959827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
    Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
    Foley RN; Murray AM; Li S; Herzog CA; McBean AM; Eggers PW; Collins AJ
    J Am Soc Nephrol; 2005 Feb; 16(2):489-95. PubMed ID: 15590763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of chronic renal failure in the elderly].
    Cobat A; Landais P
    Rev Prat; 2005 Dec; 55(20):2230-6. PubMed ID: 16519049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk stratification in chronic kidney disease: one size for all ages?
    O'Hare AM; Bertenthal D; Covinsky KE; Landefeld CS; Sen S; Mehta K; Steinman MA; Borzecki A; Walter LC
    J Am Soc Nephrol; 2006 Mar; 17(3):846-53. PubMed ID: 16452492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan.
    Hwang SJ; Tsai JC; Chen HC
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():3-9. PubMed ID: 20586940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.
    Stenvinkel P
    J Intern Med; 2010 Nov; 268(5):456-67. PubMed ID: 20809922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment.
    El Nahas M
    Nephron Clin Pract; 2010; 114(2):c103. PubMed ID: 20191694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.